Alnylam Pharmaceuticals

    About

    Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. RNAi is a revolution in biology, representing a breakthrough in understanding how genes are turned on and off in cells, and a completely new approach to drug discovery and development. Its discovery has been heralded as “a major scientific breakthrough that happens once every decade or so,” and represents one of the most promising and rapidly advancing frontiers in biology and drug discovery today, and was awarded the 2006 Nobel Prize for Physiology or Medicine.

    Focus and Stage
    Location